Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Switching on chromosomal translocations.

Almudena R Ramiro1, Michel C Nussenzweig, André Nussenzweig

  • 1DNA Hypermutation Group, Spanish National Cancer Center, Madrid, Spain. arodriguezr@cnio.es

Cancer Research
|August 17, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A CDK1 phospho-switch reprograms TRAIP to unload replisomes in mitosis.

Science (New York, N.Y.)·2026
Same author

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same author

Mapping the genetic landscape of the DNA damage response with Cas12a-based combinatorial knockout screens.

bioRxiv : the preprint server for biology·2026
Same author

DNA repair drives cisplatin-induced neuronal death.

Cell·2026
Same author

Polymeric immunoglobulin receptor deficiency attenuates experimental atherosclerosis.

Frontiers in immunology·2026
Same author

Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL.

Leukemia·2026
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026
Same journal

Retraction: Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer.

Cancer research·2026
Same journal

Editor's Note: Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.

Cancer research·2026
See all related articles

Activation-induced deaminase triggers antibody diversification and c-myc/IgH translocations. DNA checkpoints in B cells distinguish normal class switch recombination from aberrant translocations, offering insights into early cancer development.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Activation-induced deaminase (AID) is crucial for antibody diversification through class switch recombination, somatic hypermutation, and gene conversion.
  • AID's role extends beyond normal immune function, implicating it in oncogenic translocations.

Purpose of the Study:

  • To investigate the dual role of Activation-induced deaminase in both antibody diversification and the initiation of c-myc/IgH translocations.
  • To understand the molecular checkpoints that differentiate normal B cell events from malignant transformations.

Main Methods:

  • Analysis of DNA damage and oncogene-induced checkpoints in B cells.
  • Molecular pathway investigation at the early stages of malignant transformation.

Related Experiment Videos

Main Results:

  • Activation-induced deaminase can initiate Burkitt's lymphoma-associated c-myc/IgH translocations, not just antibody diversification.
  • Distinct cellular checkpoints govern whether AID activity results in normal class switch recombination or aberrant translocations.

Conclusions:

  • The study elucidates how AID contributes to both normal immune processes and oncogenesis.
  • Findings provide a foundation for studying the molecular mechanisms underlying early malignant transformation in B cells.